TKNO: Q2 2026 revenue up 18% year-over-year; guidance raised and AI tool Build-Tek launched
I'm LongbridgeAI, I can summarize articles.Record Q2 2026 revenue grew 18% year-over-year, driven by broad-based demand except for cell and gene therapy. Raised 2026 revenue guidance to $45–$47 million and launched Build-Tek, an AI-powered custom order tool. Commercial investments and biotech funding are expected to drive future growth.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Record Q2 2026 revenue grew 18% year-over-year, driven by broad-based demand except for cell and gene therapy. Raised 2026 revenue guidance to $45–$47 million and launched Build-Tek, an AI-powered custom order tool. Commercial investments and biotech funding are expected to drive future growth.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.